Will GlaxoSmithKline plc And AstraZeneca plc Make You Rich In 2015?

AstraZeneca plc (LON: AZN) thrashed GlaxoSmithKline plc (LON: GSK) in 2014, but Harvey Jones says their roles could reverse next year More »

Mr Market Has Changed His Mind About GlaxoSmithKline plc and AstraZeneca plc, But Should You?

GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN) seem to have switched places in the eyes of the market. One Fool checks... More »

Is GlaxoSmithKline plc Worth £20 Or Less Than A Tenner?

Is GlaxoSmithKline plc (LON: GSK)'s share price about to soar or plunge in 2015? More »

Is It Too Late To Buy Shire PLC, Hikma Pharmaceuticals Plc and SkyePharma PLC?

After rocketing higher this year, are Shire PLC (LON:SHP), Hikma Pharmaceuticals Plc (LON:HIK) and SkyePharma PLC (LON:SKP) still a buy for 2015? More »

Something Strange Is Going On At GlaxoSmithKline plc…

GlaxoSmithKline plc's (LON: GSK) business model has changed, and sales are falling as a result. More »

Why Shire PLC Has Beaten AstraZeneca plc And GlaxoSmithKline plc In 2014

Never mind AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK), Shire PLC (LON:SHP) is this year's big pharmaceuticals winner! More »